Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, explains why she thinks contrast-enhanced mammography will likely become the go-to supplemental imaging modality for women with dense breasts.

Radiomics methodologies could change how care plans are managed for patients with breast cancer by identifying those most likely to benefit from specific treatments.

"As the prevalence of females with tattoos increases, tattoo pigment needs to be considered as a potential differential diagnosis of breast calcification,” experts involved in the research suggested.

Connie Lehman, MD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at Massachusetts General Hospital, discusses how artificial intelligence (AI) is being implemented in breast imaging.

Stamatia Destounis, MD, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, chair of the American College of Radiology (ACR) Breast Commission, explains the rapid adoption of 3D mammogram digital breast tomosynthesis (DBT) technology.
 

Society of Breast Imaging President John Lewin, MD, explains some of the new initiatives and technology in mammography that are designed to increase early breast cancer detection.

In a new study, patients who were subject to a "humorous" intervention reported feeling less anxious during their exam and more receptive to discussions with a radiologist.